États-Unis - anglais - NLM (National Library of Medicine)

torrent pharmaceuticals limited - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone 15 mg - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . important limitation of use pioglitazone tablets exert its antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . - – initiation in patients with established nyha class iii or iv heart failure [see boxed warning] . - – use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone hydrochloride. risk summary limited data with pioglitazone hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. th

États-Unis - anglais - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone 15 mg - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . important limitations of use pioglitazone tablets exert their antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as they would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . limited data with pioglitazone tablets in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations]. in animal reproduction studies, no adverse developmental effects were observed when pioglitazone was administered to pregnant rats and rabbits during organog

États-Unis - anglais - NLM (National Library of Medicine)

encube ethicals private limited - hydrocortisone valerate (unii: 68717p8fuz) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone valerate cream usp, 0.2% is medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. hydrocortisone valerate cream usp, 0.2% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 0.05%{relative};  ;   - topical cream - 0.05 % - active: triamcinolone acetonide 0.05%{relative}     excipient: benzyl alcohol emulsifying wax glycerol isopropyl palmitate lactic acid purified water sodium hydroxide sorbitol as 70% solution

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 0.05%;  ;   - topical ointment - 0.05 % - active: triamcinolone acetonide 0.05%     excipient: white soft paraffin

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - betamethasone dipropionate 0.065%{relative} equivalent to 0.05% betmethasone;  ; betamethasone dipropionate 0.64 mg/g equivalent to 0.05% betmethasone - topical cream - 0.05% w/w - active: betamethasone dipropionate 0.065%{relative} equivalent to 0.05% betmethasone   excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin monobasic sodium phosphate dihydrate phosphoric acid purified water white soft paraffin active: betamethasone dipropionate 0.64 mg/g equivalent to 0.05% betmethasone excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin monobasic sodium phosphate dihydrate phosphoric acid purified water sodium hydroxide white soft paraffin

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - betamethasone dipropionate 0.064%{relative} equivalent to 0.05% betamethasone;   - topical ointment - 0.05% w/w - active: betamethasone dipropionate 0.064%{relative} equivalent to 0.05% betamethasone   excipient: liquid paraffin white soft paraffin

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - fluticasone propionate 0.05%{relative};   - nasal spray suspension - 0.05% w/w - active: fluticasone propionate 0.05%{relative}   excipient: benzalkonium chloride dispersible cellulose glucose hydrochloric acid phenethyl alcohol polysorbate 80 purified water - flixonase allergy & hayfever 24 hour is indicated for the prophylaxis and treatment of allergic rhinitis including hay fever and that caused by other airborne allergens such as house dust mite, mould spores and animal dander. during treatment flixonase allergy & hayfever 24 hour provides symptomatic relief of sneezing, itchy and runny nose, congestion including associated sinus discomfort and pressure around the nose and eyes. flixonase allergy & hayfever 24 hour also provides relief of ocular symptoms associated with allergic rhinitis.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - clobetasol propionate - cream - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol

Irlande - anglais - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - clobetasol propionate - ointment - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol